Stock 6446 PHARMAESSENTIA CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Calendar PharmaEssentia Corporation

Equities

6446

TW0006446008

End-of-day quote Taiwan S.E.
Other stock markets
 06:00:00 2024-05-16 pm EDT 		5-day change 1st Jan Change
408.5 TWD +5.28% Intraday chart for PharmaEssentia Corporation +30.72% +18.06%
May. 13 PharmaEssentia Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 26 PharmaEssentia Corp. Submits Phase III Clinical Study Protocol of P1101 for Pre-fibrotic/ Early PMF or OvertPMF at Low to Intermediate-1 Risk to China NMPA CI

Chart calendar PharmaEssentia Corporation

8af2d973585.yqYBqk1vyifWINbgnrAM6cA2-xFWYHzWUq0HeK5I8XA.q-JY3QMj-3TnE_u2p4A8u4F5w2AFNRaJJtdGGckCpD2O4zXFewCeSPtLuQ~15ca0da30b7a3113bb01980795673c24

Upcoming events on PharmaEssentia Corporation

2024-05-26 10:00 pm Annual General Meeting
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-02 Q4 2024 Earnings Release (Projected)
2025-05-18 Q1 2025 Earnings Release (Projected)

Past events on PharmaEssentia Corporation

2024-05-12 Q1 2024 Earnings Release
2024-05-05 02:03 am April 2024 Sales and Revenue Release
2024-04-08 04:10 am Biotechnology and Medical Care Industry Investor Conference
2024-04-04 10:15 pm March 2024 Sales and Revenue Release
2024-03-05 03:39 am February 2024 Sales and Revenue Release
2024-02-26 01:00 am MasterLink Securities Investor Conference
2024-02-26 12:41 am Q4 2023 Earnings Release
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract Number #4575
2023-11-02 05:15 pm Myeloproliferative Neoplasms International Congress - Abstract Number #116
2023-11-02 05:15 pm Myeloproliferative Neoplasms International Congress - Abstract Number #137
2023-11-02 05:15 pm Myeloproliferative Neoplasms International Congress - Abstract Number #133
2023-11-02 05:15 pm Myeloproliferative Neoplasms International Congress - Abstract Number #141
2023-11-02 05:15 pm Myeloproliferative Neoplasms International Congress - Abstract Number #127
2023-01-09 JP Morgan Healthcare Conference
2022-12-12 American Society of Hematology Meeting - Abstract No 4345
2022-12-11 American Society of Hematology Meeting - Abstract No 3050
2022-12-11 American Society of Hematology Meeting - Abstract No 3004
2022-11-30 08:00 am Investor Day
2021-01-11 10:25 am JP Morgan Healthcare Conference
2020-12-06 05:30 pm American Society of Hematology Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million TWD		Released
Forecast
Spread 		306
267
14.49%		557
753
-26.03%		657
701
-6.3%		2 882
2 882
0%		5 106
5 589
-8.65%
8 772

EBITDA
Million TWD		Released
Forecast
Spread 		-712
-886
19.62%		-1 541
-721
-113.89%		-2 595
-2 509
-3.46%		-1 800
-1 786
-0.8%		-1 645
-1 577
-4.26%
2 255

EBIT
Million TWD		Released
Forecast
Spread 		-849
-973
12.72%		-1 716
-979
-75.21%		-2 822
-2 641
-6.87%		-2 028
-2 012
-0.8%		-1 913
-1 373
-39.33%
1 200

Earnings before Tax (EBT)
Million TWD		Released
Forecast
Spread 		-842
-966
12.82%		-1 948
-964
-102.01%		-2 811
-2 700
-4.1%		-1 842
-1 808
-1.87%		-987
-1 446
31.75%
1 885

Net income
Million TWD		Released
Forecast
Spread 		-843
-966
12.73%		-1 948
-965
-101.95%		-2 811
-2 700
-4.1%		-1 375
-1 808
23.96%		-624
-1 418
56.01%
1 628

EPS
TWD		Released
Forecast
Spread 		-3,85
-4,41
12.7%		-8,04
-3,78
-112.7%		-10,8
-10,1
-6.58%		-4,84
-5,98
19.06%		-1,93
-4,72
59.11%
4,92

Announcement Date26/02/2003/03/2102/03/2201/03/2327/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million TWD		Released
Forecast
Spread 		252
266
-5.48%		978
1 196
-18.25%		811
811
-0.02%		842
842
-0.03%		888
930
-4.55%		1 265
1 144
10.56%		1 306
1 716
-23.88%		1 647
2 223
-25.92%		1 653
1 781
-7.16%
2 045


2 363


2 825

EBITDA
Million TWD		Released
Forecast
Spread 		-491
-327
-50.05%		-270
-349
22.5%		-511
-471
-8.4%
-309




-349
-546
36.1%		-586
-124
-372.28%
-98,0













EBIT
Million TWD		Released
Forecast
Spread 		-557
-897
37.91%		-327
-118
-176.78%		-565
-424
-33.23%		-580
-563
-2.97%		-725
-574
-26.39%		-405
-434
6.62%		-645
-187
-244.94%		-132
-39,0
-238.75%		17,6
3,00
486.17%
158


408


790

Earnings before Tax (EBT)
Million TWD		Released
Forecast
Spread 		-541
-896
39.64%		-275
-115
-138.87%		-409
-421
2.89%		-617
-584
-5.73%		-760
-575
-32.18%		-203
-435
53.27%		191
-191
199.93%		-215
-378
43.19%		335
238
40.59%
276


526


916

Net income
Million TWD		Released
Forecast
Spread 		-541
-896
39.64%		-275
-115
-138.87%		-409
-421
2.89%		-150
-584
74.25%		-736
-575
-27.92%		-203
-435
53.34%		199
-191
203.94%		116
-378
130.67%		330
230
43.65%
223


424


736

EPS
TWD		Released
Forecast
Spread 		-1,96
-3,14
37.58%		-0,98
-0,40
-145%		-1,44
-1,39
-3.6%		-0,47
-1,93
75.65%		-2,44
-1,90
-28.42%		-0,62
-1,40
55.56%		0,66
-0,63
204.76%		0,38
-1,27
129.92%		0,99
0,77
28.57%
0,67


1,27


2,20

Announcement Date16/05/2212/08/2214/11/2201/03/2311/05/2310/08/2309/11/2327/02/2413/05/24---

Upcoming sector events for PharmaEssentia Corporation

2024-07-23 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-24 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-25 01:00 am ARGENX SE: Q2 2024 Earnings Release
2024-07-29 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for PharmaEssentia Corporation

2024-05-17 07:00 am AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
2024-05-16 07:46 am BIOCON LIMITED: Q4 2024 Earnings Release
2024-05-16 01:00 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
2024-05-15 08:05 am THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 am CABALETTA BIO, INC.: Q1 2024 Earnings Release
2024-05-14 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
2024-05-15 04:01 pm CELCUITY INC.: Q1 2024 Earnings Release
2024-05-14 04:05 pm ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 04:00 pm ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 08:00 am IMMUNOME, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 6446 Stock
  4. Calendar PharmaEssentia Corporation
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW